(Q51039680)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795540%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

The role of OX40 (CD134) in T-cell memory generation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795540%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Andrew D Weinberg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795540%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795540%20AND%20SRC:MED&resulttype=core&format=json

Advances in Experimental Medicine and Biology

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795540%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795540%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

57-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795540%20AND%20SRC:MED&resulttype=core&format=json

Induction and maintenance of anergy in mature T cells

12 February 2020

cites work

1 reference

12 December 2020

Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)

1 reference

12 December 2020

1 reference

12 December 2020

The effect of TCR V beta 8 peptide protection and therapy on T cell populations isolated from the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis

1 reference

12 December 2020

A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes

1 reference

12 December 2020

Differential requirements for OX40 signals on generation of effector and central memory CD4+ T cells.

1 reference

12 December 2020

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

12 December 2020

OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response

1 reference

12 December 2020

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

1 reference

12 December 2020

OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent

1 reference

12 December 2020

OX-40: life beyond the effector T cell stage.

1 reference

12 December 2020

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

1 reference

12 December 2020

Immunohistochemical analysis of primary breast tumors and tumor-draining lymph nodes by means of the T-cell costimulatory molecule OX-40.

1 reference

12 December 2020

Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34

1 reference

12 December 2020

Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions

1 reference

12 December 2020

During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion

1 reference

12 December 2020

OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines

1 reference

12 December 2020

Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?

1 reference

12 December 2020

IL-12 is required for anti-OX40-mediated CD4 T cell survival.

1 reference

12 December 2020

Immunostimulatory monoclonal antibodies for cancer therapy

1 reference

12 December 2020

CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells.

1 reference

12 December 2020

Memory CD8 T-cell differentiation during viral infection

1 reference

12 December 2020

OX40 and Bcl-xL promote the persistence of CD8 T cells to recall tumor-associated antigen.

1 reference

12 December 2020

CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells

1 reference

12 December 2020

OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism.

1 reference

12 December 2020

The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response

1 reference

12 December 2020

Anti-OX40 (CD134) administration to nonhuman primates: immunostimulatory effects and toxicokinetic study

1 reference

12 December 2020

Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts

1 reference

12 December 2020

V beta CDR3 motifs associated with BP recognition are enriched in OX-40+ spinal cord T cells of Lewis rats with EAE

1 reference

12 December 2020

The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells

1 reference

12 December 2020

Targeting OX40 and OX40L for the treatment of autoimmunity and cancer

1 reference

12 December 2020

OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation

1 reference

12 December 2020

Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice

1 reference

12 December 2020

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

12 December 2020

Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand

1 reference

12 December 2020

Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.

1 reference

12 December 2020

OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection

1 reference

12 December 2020

Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses

1 reference

12 December 2020

Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis

1 reference

12 December 2020

Functional expression of CD134 by neutrophils.

1 reference

12 December 2020

Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor

1 reference

12 December 2020

Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses

1 reference

12 December 2020

Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions

1 reference

12 December 2020

Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist

1 reference

12 December 2020

Expression and function of OX40 ligand on human dendritic cells

1 reference

12 December 2020

OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity

1 reference

12 December 2020

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

12 December 2020

Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers

1 reference

12 December 2020

Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands

1 reference

12 December 2020

OX40 ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia

1 reference

12 December 2020

Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax

1 reference

12 December 2020

Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.

1 reference

12 December 2020

Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor

1 reference

12 December 2020

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

1 reference

12 December 2020

Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.

1 reference

12 December 2020

Fc-mOX40L fusion protein produces complete remission and enhanced survival in 2 murine tumor models

1 reference

12 December 2020

Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40.

1 reference

12 December 2020

Effector and memory T-cell differentiation: implications for vaccine development

1 reference

12 December 2020

OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen

1 reference

12 December 2020

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

1 reference

12 December 2020

CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles

1 reference

12 December 2020

The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells

1 reference

12 December 2020

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion

1 reference

12 December 2020

Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth.

1 reference

12 December 2020

Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.

1 reference

12 December 2020

10.1007/978-1-4419-6451-9_5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795540%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference